Publications

Targeted Photodynamic Therapy for Prostate Cancer: Inducing Apoptosis via Activation of the Caspase-8/3 Cascade Pathway. Liu, T.; Wu, L.Y.; Choi, J.K.*; Berkman, C.E. Int. J. Oncol. 2010 36:p. 777-784.PDF

Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer. Lapi, S.E., et al., J Nucl Med, 2009. 50(12): p. 2042-8.PDF

Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid. Yao, V., et al., Prostate, 2009.PDF

In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen. Liu, T., et al., Prostate, 2009. 69(6): p. 585-94.PDF

Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimetics. Liu, T., et al., Biochemistry, 2008. 47(48): p. 12658-60.PDF

Cell-Surface labeling and internalization by a fluorescent inhibitor of prostate-specific membrane antigen. Liu, T., et al., Prostate, 2008. 68(9): p. 955-64.PDF

Phosphoramidate derivatives of hydroxysteroids as inhibitors of prostate-specific membrane antigen. Wu, L.Y., et al., Bioorg Med Chem Lett, 2008. 18(1): p. 281-4.PDF;

The molecular pruning of a phosphoramidate peptidomimetic inhibitor of prostate-specific membrane antigen. Wu, L.Y., et al., Bioorg Med Chem, 2007. 15(23): p. 7434-43.PDF

Substrate specificity of prostate-specific membrane antigen. Anderson, M.O., et al., Bioorg Med Chem, 2007. 15(21): p. 6678-86.PDF

Purification of prostate-specific membrane antigen using conformational epitope-specific antibody-affinity chromatography. Liu, T., Y. Toriyabe, and C.E. Berkman, Protein Expr Purif, 2006. 49(2): p. 251-5.PDF

Optimizing phenylethylphosphonamidates for the inhibition of prostate-specific membrane antigen. Wone, D.W., et al., Bioorg Med Chem, 2006. 14(1): p. 67-76.PDF

Probing for a hydrophobic a binding register in prostate-specific membrane antigen with phenylalkylphosphonamidates. Maung, J., et al., Bioorg Med Chem, 2004. 12(18): p. 4969-79.PDF

High-performance liquid chromatography method for detecting prostate-specific membrane antigen activity. Kamga, I., et al., Anal Biochem, 2002. 310(1): p. 125-7.PDF